Over-the-Counter Diagnostic Products World Markets – Aarkstore Enterprise

The purpose of this Publications analysis is to describe the specific market segments of the over-the-counter (OTC) diagnostic products and home healthcare markets. It examines the diagnostic measurement devices and their reagents and supplies that are utilized in clinics and by patients directly in their homes to diagnose and monitor disease. This study also includes a review of home healthcare kits and devices that measure health-related conditions. Focus is on market dynamics and current market drivers of the OTC and home self-testing diagnostics market. This report also looks at the industry challenges and potential threats, and it makes strategic recommendations for boosting market share. The analysis covers healthcare-related devices that are designed for the home market in order to allow consumers to assess their health status through self-testing. In addition, this review examines some biowarfare detection systems. The emphasis in this report is on those companies and products that are actively developing and marketing diagnostic reagents and supplies in market segments that are targeted for direct sale to the public. It is believed that this market segment has the potential for growth rates above 15% per year over the next five years in some of the less well-explored and well-developed areas. 
 
 Table of Contents : 
1 Overview 7
1.1 Statement of Report 7
1.2 About This Report 7
1.3 Scope of the Report 9
1.4 Objectives 10
1.5 Methodology 11
1.6 Executive Summary 11

2 Sector Overview 17
2.1 Global Diagnostic Products Industry 17
2.2 Global OTC Diagnostic Products Industry 18
2.2.1 General Global Market 18
2.2.2 German OTC and Home Self-Testing Diagnostic Markets 22
2.2.3 U.K. OTC and Home Self-Test Diagnostic Markets 22
2.2.3.1 U.K. Market Statistics 23
2.2.3.2 U.K. Competitive Analysis 24
2.2.3.3 U.K. Market Access 25
2.2.4 French OTC Diagnostic Market 25
2.2.5 Italian OTC Diagnostic Market 26
2.2.6 Spanish OTC Diagnostic Market 26
2.2.7 Japanese OTC Diagnostic Market 27
2.2.8 Chinese OTC Diagnostic Market 28
2.3 Description of the U.S. OTC Diagnostics Industry Segment 29
2.3.1 Market Overview 29
2.3.2 Diagnostic Test Categories 30
2.4 Market Drivers in the OTC Diagnostics Sector 31
2.4.1 Overview 31
2.4.2 Market Segments 31
2.5 Key Players in the OTC Diagnostics Segment 32
2.6 Sector Analysis 34
 
For More Information, Kindly Visit :
http://www.aarkstore.com/reports/Over-the-Counter-Diagnostic-Products-World-Markets-1331.html

Welcome to Aarkstore Market Research Aggregation

We specialize in providing online market business information on market research reports, books, magazines, conference booking at competitive prices, and strive to provide excellent and innovative service to our customers. We are built on the premise that reading is valuable, capable of stirring emotions and firing the imagination. Whether you’re looking for new product trends or competitive analysis of a new or existing market, Aarkstore.com has the best resource offerings and the expertise to make sure you get the right product every time. 
 
http://www.aarkstore.com

Point of Care Diagnostic Testing World Markets

The purpose of this report is to describe the specific market segment of the in vitro diagnostics market called point of care testing (POCT). It examines these clinical measurement devices and their reagents and supplies as utilized in near-patient enviroments like hospitals, clinics and doctor’s offices. An analysis of analytes that are related to the common chemical constituents of blood, plasma or serum at the point of care of the patient is addressed. Moreover, the study defines the dollar volume of sales, both worldwide and in the U.S., and analyzes the factors that influence the size and the growth of the market segments. Also examined are the subsections of each market segment, including the research labs, hospital labs and commercial laboratories. Additionally, rapid detection of food pathogens and infectious pathogens (MRSA, herpes simplex, avian flu, West Nile virus and typhoid) are discussed. The report surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the point of care market in the U.S. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company’s market position.
 

To know more about this report, please visit the below link :http://www.aarkstore.com/reports/Point-of-Care-Diagnostic-Testing-World-Markets-1337.html

Point of Care Diagnostic Testing Sector Trends

The purpose of this TriMark Publications report is to describe the sector trends within the point of care testing (POCT) diagnostic market. It examines those measurement devices and their reagents and supplies that are utilized in hospitals, clinics, commercial laboratories and research institutions to detect cells and proteins for the purpose of diagnosis and monitoring of disease. This study includes all of the generally-accepted clinical analytical activities that are currently in use today. Additionally, an analysis of business and technology trends and developing areas of point of care and HPV testing is provided, along with a review of the market for point of care testing equipment and supplies in the clinical and research market segments, using screening reagents and instruments for analysis of individual components in blood, serum or plasma. This report defines U.S. and global market dollar sales volume and analyzes factors that influence the size and growth of market segments.

To know more about this report, please visit the below link :http://www.aarkstore.com/reports/Point-of-Care-Diagnostic-Testing-Sector-Trends-1333.html

Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in ‘Theranostics’ and Personalized Medicine)

This Kalorama Information report, Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) is truly a real-world guide to the potential market for companion diagnostics.

Essentially the co-development of testing products to enhance the value and efficacy of a therapeutic, companion diagnostics is widely seen as an important growth strategy in both the diagnostic and pharmaceutical industries. It is envisioned as a pathway to personalized medicine, where the right therapeutic is selected for the right patient. Personalized medicine is one of the key trends in healthcare, and it’s no surprise that there is great enthusiasm in many quarters of the in vitro industry, pharmaceutical companies and the investment community about companion diagnostics. But will the concept work in the fashion that the industry is envisioning? Who will succeed and with what strategy? How much can companies expect to earn in this field? What strategies should companies adopt to thrive in this market?

In this report, Kalorama Information analyst Kenneth Krul, PhD. brings a real-world view to the concept of companion diagnostics and the likely scenario given market conditions. He addresses the myriad challenges that diagnostic and pharmaceutical companies will face in this endeavor. He outlines strategies that will be more successful. His analysis includes:

• A Complete Explanation of Companion Diagnostics
• Realistic Market Forecasts for the Companion Diagnostics to 2018
• A Glossary of Terms Used in this Industry
• Review of Collaborations Between Pharma and Diagnostic Companies
• Possible Pitfalls the Companion Diagnostic Concept will Face.
• Companies Best Poised to Profit From This Market
• 10 Strategic Conclusions about the Market and Implications for Marketers
• The Key Therapeutic Areas Where Companion Diagnostics Could Succeed.
• The Best Approaches for Companion Diagnostics Marketing

As with all Kalorama Information reports, this report is the result of analysis from a professional in the industry combined with thorough research and interviews with experts. Our interview-based methodology uncovers insight about market not possible from reports based on culled information.

The following companies and their efforts in companion diagnostics are profiled in this report:

• Abbott Diagnostics
• Affymetrix, Inc
• Agilent Technologies, Inc
• Althea Technologies, Inc
• Curidium Medica plc
• Dako
• Gen Probe
• Genzyme Corporation
• Ipsogen SAS
• Lipomics Technologies, Inc.
• Osmetech plc
• Perlegen Sciences
• Provista Life Sciences
• Qiagen NV
• Singulex, Inc.
• Theranostics Health
• Ventana Medical Systems

For more information, please visit : http://www.aarkstore.com/reports/Companion-Diagnostics-Markets-A-Realistic-Assessment-of-the-Opportunities-Challenges-Key-Players-and-Important-Trends-in-Theranostics-and-Personalized-Medicine–12924.html  Or email us at press@aarkstore.com or call +919272852585.

Diagnostic Test Service Commercialization in Multiplex and Esoteric Testing: A Roadmap to Diagnostics in the 21st Century

Test services, once the norm in the diagnostics industry, then abandoned for reagent sales, are now making a comeback.

IVD companies have established cGMP and CLIA-registered labs by which they offer their proprietary tests to physicians, hospitals and reference labs. These tests are outside the oversight of the traditional FDA and CE Mark test commercialization avenue in the U.S, and Europe and so are thought to come to market by what may seem to be the back door.

Kalorama has been watching this trend, and in her unique report, Kalorama Information’s diagnostic analyst Shara Rosen covers the increasing trend in diagnostics towards servicing of tests in addition to selling test kit products and where this fits into the IVD industry today.

 

Information in this report includes

• Current market and forecast for diagnostics test services
• Detailed Analysis of the Esoteric Test Market
• Review of Current Products on the Market
• Test Service Revenue Breakdown for Major Companies
• Evaluation of Test Services Products on the Market According to Five Checkpoints
• Strategies for Success In Test Service Commercialization
• Company Profiles

(Clinical Chemistry, Immunoassays, Radioimmunoassays, Coagulation, Histology/Cytology, Nucleic Acid Assays, Flow Cytometry)

The report covers Clinical test services offered by reference laboratories, hospital laboratory outreach programs, direct to consumer web-based companies, and CLIA-registered company labs. The report describes the lay of the land for test services when they were first launched in the mid 1980s, the status quo in 2008 and a peek into the future.

 

What are the market factors driving test servicing? What companies are best suited for this strategy now and in the future? What are the best strategies, who has been most successful and where is this trend headed in the future? What are the areas of IVD most likely to be impacted by this trend.? This report answers these questions and more. Rosen’s report will not only describe the market as it is today, but provide a clear picture – a roadmap – to how diagnostics will be practiced in this century.

Shara Rosen is Kalorama’s lead diagnostic analyst and is the author of the Worldwide Market for In Vitro Diagnostics, 6th Edition., Physician Office Lab Markets,Point of Care Diagnostics and several other important diagnostic studies. This study is the result of her research and analysis and interviews with experts in the field.
For more information, please visit : http://www.aarkstore.com/reports/Diagnostic-Test-Service-Commercialization-in-Multiplex-and-Esoteric-Testing-A-Roadmap-to-Diagnostics-in-the-21st-Century-12917.html  Or email us at press@aarkstore.com or call +919272852585.

Global In Vitro Diagnostics (IVD) Market: An Analysis

The global In Vitro Diagnostic (IVD) industry is witnessing a period of profound growth. The growth is coming from different regions and markets. The various sub-segments of IVD are also giving the industry a big push. The increase in the aging population is also driving the demand of IVD devices world over. The industry is getting a push from every side and many factors collectively are fuelling the growth in this industry. Moreover, as the medical devices and diagnostic in total account for a very small proportion of the total healthcare spending, the IVD industry can be seen as having a tremendous opportunity for growth.

The emerging markets are a big driving force for this industry. These markets are fast catching up with the mature markets in terms of spending. The mature markets, on the other hand, are leading in terms of spending. These markets are already huge in size and are continuously growing.

The various sub-segments of IVD industry are growing at different paces. The various diseases like chronic and infectious diseases are increasing globally. Moreover, people have become highly conscious of their health and prevention of diseases. Moreover as countries make the healthcare more and more accessible to people, the demand for various IVD devices is increasing.

The report focuses specifically on the in vitro diagnostic market. The report covers the IVD industry from two different perspectives. One is the various sub-segments of the industry, their market size, growth. Secondly, the IVD market is being covered from the regional point of view. The top regional markets are being analyzed.

The growth drivers, key trends of the market and current issues faced by the industry are also discussed. Competition in the industry and competitive positions of major players, taking different parameters is also highlighted. Apart from this the major global players are profiled along with the insight into their financial positions and the strategies these players are planning to maintain their respective positions in the market.

To know more about this report, please visit the below link :
http://www.aarkstore.com/reports/Global-In-Vitro-Diagnostics-IVD-Market-An-Analysis-6584.htmlor email us for any queries at press@aarkstore.com